Yousaf Muhammad Nadeem, Naqvi Haider A, Kane Shriya, Chaudhary Fizah S, Hawksworth Jason, Nayar Vikram V, Faust Thomas W
Division of Gastroenterology and Hepatology, Department of Medicine, University of Missouri, Columbia, MO 65212, United States.
Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD 21218, United States.
World J Hepatol. 2023 May 27;15(5):715-724. doi: 10.4254/wjh.v15.i5.715.
Ventriculoperitoneal (VP) shunt placement has become a standard of care procedure in managing hydrocephalus for drainage and absorption of cerebrospinal fluid (CSF) into the peritoneum. Abdominal pseudocysts containing CSF are the common long-term complication of this frequently performed procedure, mainly because VP shunts have significantly prolonged survival. Of these, liver CSF pseudocysts are rare entities that may cause shunt dysfunction, affect normal organ function, and therefore pose therapeutic challenges.
A 49-year-old man with history of congenital hydrocephalus status post bilateral VP shunt placement presented with progressively worsening dyspnea on exertion, abdominal discomfort/distention. Abdominal computed tomography (CT) scan revealed a large CSF pseudocyst in the right hepatic lobe with the tip of VP shunt catheter into the hepatic cyst cavity. Patient underwent robotic laparoscopic cyst fenestration with a partial hepatectomy, and repositioning of VP shunt catheter to the right lower quadrant of the abdomen. Follow-up CT demonstrated a significant reduction in hepatic CSF pseudocyst.
A high index of clinical suspicion is required for early detection of liver CSF pseudocysts since their presentation is often asymptomatic and cunning early in the course. Late-stage liver CSF pseudocysts could have adverse outcomes on the treatment course of hydrocephalus as well as on hepatobiliary dysfunction. There is paucity of data to define the management of liver CSF pseudocyst in current guidelines due to rare nature of this entity. The reported occurrences have been managed by laparotomy with debridement, paracentesis, radiological imaging guided fluid aspiration and laparoscopic-associated cyst fenestration. Robotic surgery is an additional minimally invasive option in the management of hepatic CSF pseudocyst; however, its use is limited by lack of widespread availability and cost of surgery.
脑室腹腔(VP)分流术已成为治疗脑积水的标准护理程序,用于将脑脊液(CSF)引流并吸收至腹膜。含有脑脊液的腹部假性囊肿是这种常见手术的常见长期并发症,主要是因为VP分流术显著延长了患者的生存期。其中,肝脑脊液假性囊肿是罕见的实体,可能导致分流功能障碍,影响正常器官功能,因此带来治疗挑战。
一名49岁男性,有先天性脑积水病史,曾接受双侧VP分流术,现出现劳力性呼吸困难进行性加重、腹部不适/腹胀。腹部计算机断层扫描(CT)显示右肝叶有一个大的脑脊液假性囊肿,VP分流导管尖端进入肝囊肿腔。患者接受了机器人辅助腹腔镜囊肿开窗术并部分肝切除术,以及将VP分流导管重新放置到腹部右下腹。随访CT显示肝脑脊液假性囊肿明显缩小。
由于肝脑脊液假性囊肿早期通常无症状且隐匿,因此早期检测需要高度的临床怀疑。晚期肝脑脊液假性囊肿可能对脑积水的治疗过程以及肝胆功能障碍产生不良后果。由于该实体罕见,目前指南中缺乏定义肝脑脊液假性囊肿管理的数据。已报道的病例通过剖腹清创术、穿刺抽液、放射影像引导下液体抽吸和腹腔镜相关囊肿开窗术进行治疗。机器人手术是治疗肝脑脊液假性囊肿的另一种微创选择;然而,其应用受到缺乏广泛可用性和手术成本的限制。